212 related articles for article (PubMed ID: 36029394)
1. PHOX2B is a Sensitive and Specific Marker for the Histopathological Diagnosis of Pheochromocytoma and Paraganglioma.
Miyauchi M; Akashi T; Furukawa A; Uchida K; Tamura T; Ando N; Kirimura S; Shintaku H; Yamamoto K; Ito T; Miura K; Kayamori K; Ariizumi Y; Asakage T; Kudo A; Tanabe M; Fujii Y; Ishibashi H; Okubo K; Murakami M; Yamada T; Takemoto A; Bae Y; Eishi Y; Ohashi K
Endocr Pathol; 2022 Dec; 33(4):506-518. PubMed ID: 36029394
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Expression of Choline Acetyltransferase and Catecholamine-Synthesizing Enzymes in Head-and-Neck and Thoracoabdominal Paragangliomas and Pheochromocytomas.
Kimura N; Shiga K; Kaneko KI; Oki Y; Sugisawa C; Saito J; Tawara S; Akahori H; Sogabe S; Yamashita T; Takekoshi K; Naruse M; Katabami T
Endocr Pathol; 2021 Dec; 32(4):442-451. PubMed ID: 34743284
[TBL] [Abstract][Full Text] [Related]
3. The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma.
Kimura N; Shiga K; Kaneko K; Sugisawa C; Katabami T; Naruse M
Endocr Pathol; 2020 Jun; 31(2):95-100. PubMed ID: 32303954
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
[TBL] [Abstract][Full Text] [Related]
5. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract][Full Text] [Related]
6. Management of pheochromocytomas and paragangliomas: Review of current diagnosis and treatment options.
Eid M; Foukal J; Sochorová D; Tuček Š; Starý K; Kala Z; Mayer J; Němeček R; Trna J; Kunovský L
Cancer Med; 2023 Jul; 12(13):13942-13957. PubMed ID: 37145019
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors.
Mamilla D; Manukyan I; Fetsch PA; Pacak K; Miettinen M
Hum Pathol; 2020 Sep; 103():72-82. PubMed ID: 32668278
[TBL] [Abstract][Full Text] [Related]
8. Clinical management of paragangliomas.
Corssmit EP; Romijn JA
Eur J Endocrinol; 2014 Dec; 171(6):R231-43. PubMed ID: 25063320
[TBL] [Abstract][Full Text] [Related]
9. Phox2B is a sensitive and reliable marker of paraganglioma-Phox2B immunohistochemistry in diagnosis of neuroendocrine neoplasms.
Manethova M; Gerykova L; Faistova H; Drugda J; Hacova M; Hornychova H; Ryska A; Gabalec F; Soukup J
Virchows Arch; 2023 Apr; 482(4):679-686. PubMed ID: 36656393
[TBL] [Abstract][Full Text] [Related]
10. Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.
Gimm O; DeMicco C; Perren A; Giammarile F; Walz MK; Brunaud L
Langenbecks Arch Surg; 2012 Feb; 397(2):155-77. PubMed ID: 22124609
[TBL] [Abstract][Full Text] [Related]
11. Examination of PHOX2B in adult neuroendocrine neoplasms reveals relatively frequent expression in phaeochromocytomas and paragangliomas.
Lee JP; Hung YP; O'Dorisio TM; Howe JR; Hornick JL; Bellizzi AM
Histopathology; 2017 Oct; 71(4):503-510. PubMed ID: 28464318
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism.
Tevosian SG; Ghayee HK
J Clin Endocrinol Metab; 2018 May; 103(5):1779-1789. PubMed ID: 29409060
[TBL] [Abstract][Full Text] [Related]
13. LncRNA expression and SDHB mutations in pheochromocytomas and paragangliomas.
Li H; Hardin H; Zaeem M; Huang W; Hu R; Lloyd RV
Ann Diagn Pathol; 2021 Dec; 55():151801. PubMed ID: 34461576
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma.
Karakaya S; Gunnesson L; Elias E; Martos-Salvo P; Robledo M; Nilsson O; Wängberg B; Abel F; Påhlman S; Muth A; Mohlin S
Sci Rep; 2023 Jul; 13(1):11588. PubMed ID: 37463949
[TBL] [Abstract][Full Text] [Related]
15. The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas.
Oudijk L; Papathomas T; de Krijger R; Korpershoek E; Gimenez-Roqueplo AP; Favier J; Canu L; Mannelli M; Rapa I; Currás-Freixes M; Robledo M; Smid M; Papotti M; Volante M
Neuroendocrinology; 2017; 105(4):384-393. PubMed ID: 28122379
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.
Currás-Freixes M; Inglada-Pérez L; Mancikova V; Montero-Conde C; Letón R; Comino-Méndez I; Apellániz-Ruiz M; Sánchez-Barroso L; Aguirre Sánchez-Covisa M; Alcázar V; Aller J; Álvarez-Escolá C; Andía-Melero VM; Azriel-Mira S; Calatayud-Gutiérrez M; Díaz JÁ; Díez-Hernández A; Lamas-Oliveira C; Marazuela M; Matias-Guiu X; Meoro-Avilés A; Patiño-García A; Pedrinaci S; Riesco-Eizaguirre G; Sábado-Álvarez C; Sáez-Villaverde R; Sainz de Los Terreros A; Sanz Guadarrama Ó; Sastre-Marcos J; Scolá-Yurrita B; Segura-Huerta Á; Serrano-Corredor Mde L; Villar-Vicente MR; Rodríguez-Antona C; Korpershoek E; Cascón A; Robledo M
J Med Genet; 2015 Oct; 52(10):647-56. PubMed ID: 26269449
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytomas and paragangliomas in humans and dogs.
Galac S; Korpershoek E
Vet Comp Oncol; 2017 Dec; 15(4):1158-1170. PubMed ID: 28120550
[TBL] [Abstract][Full Text] [Related]
18. Hand2 Immunohistochemistry in the Diagnosis of Paragangliomas and Other Neuroendocrine Neoplasms.
Soukup J; Manethova M; Stejskal V; Novakova M; Duskova J; Hornychova H; Hacova M; Staniczkova-Zambo I; Zelinka T; Kosak M; Cesak T; Netuka D; Ryska A; Gabalec F
Endocr Pathol; 2024 Mar; 35(1):14-24. PubMed ID: 38416360
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and management of metastatic pheochromocytoma and paraganglioma].
Jochmanová I; Lazúrová I
Vnitr Lek; 2017; 63(9):580-588. PubMed ID: 29120654
[TBL] [Abstract][Full Text] [Related]
20. Secondary hypertension: An update on the diagnosis and localisation of a pheochromocytoma or paraganglioma.
Siddiqui N; Daya R; Seedat F; Bulbulia S; Bayat Z
S Afr Fam Pract (2004); 2021 Jul; 63(1):e1-e6. PubMed ID: 34342483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
